Treatment of atopic dermatitis with the xenon chloride excimer laser
Background Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B...
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2006-07, Vol.20 (6), p.657-660 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 660 |
|---|---|
| container_issue | 6 |
| container_start_page | 657 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 20 |
| creator | Baltás, E Csoma, Z Bodai, L Ignácz, F Dobozy, A Kemény, L |
| description | Background Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow‐band ultraviolet B.
Objective The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis.
Patients and methods Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus.
Results After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side‐effects were observed.
Conclusion These results suggest that the xenon chloride excimer laser is an effective and well‐tolerated treatment for localized atopic dermatitis. |
| doi_str_mv | 10.1111/j.1468-3083.2006.01495.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68642712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68642712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4055-53588bb74d9c6a2566c9b606f8716f63960194f12d61a60942a79ce3e02535be3</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhi0EotvCX0A-cUvwRzyJDxxQF5aiVZFQaREXy3EmWi_JZmt71fTfk7Cr9spcZqR5nxnpIYRylvOpPmxzXkCVSVbJXDAGOeOFVvn4giyeFi_JgmkBmdZKn5HzGLeMMc5V9ZqccagkFJovyPImoE097hIdWmrTsPeONhh6m3zykT74tKFpg3TE3bCjbtMNwTdIcXS-x0A7GzG8Ia9a20V8e-oX5OeXzzeXX7P199XV5ad15gqmVKakqqq6LotGO7BCAThdA4O2Kjm0IDUwrouWiwa4BaYLYUvtUCITE1qjvCDvj3f3Ybg_YEym99Fh19kdDodooIJClFxMweoYdGGIMWBr9sH3Njwazsxs0GzNLMrMosxs0PwzaMYJfXf6cah7bJ7Bk7Ip8PEYePAdPv73YfNteTtPE58deR8Tjk-8DX8MlLJU5u56ZZa_1Ur8kGvzS_4Fv_2NNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68642712</pqid></control><display><type>article</type><title>Treatment of atopic dermatitis with the xenon chloride excimer laser</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Baltás, E ; Csoma, Z ; Bodai, L ; Ignácz, F ; Dobozy, A ; Kemény, L</creator><creatorcontrib>Baltás, E ; Csoma, Z ; Bodai, L ; Ignácz, F ; Dobozy, A ; Kemény, L</creatorcontrib><description>Background Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow‐band ultraviolet B.
Objective The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis.
Patients and methods Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus.
Results After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side‐effects were observed.
Conclusion These results suggest that the xenon chloride excimer laser is an effective and well‐tolerated treatment for localized atopic dermatitis.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/j.1468-3083.2006.01495.x</identifier><identifier>PMID: 16836491</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; atopic dermatitis ; Chlorides ; Dermatitis, Atopic - pathology ; Dermatitis, Atopic - therapy ; excimer laser ; Female ; Humans ; Laser Therapy - adverse effects ; Laser Therapy - methods ; Male ; phototherapy ; Quality of Life ; Severity of Illness Index ; Surveys and Questionnaires ; Treatment Outcome ; Xenon</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2006-07, Vol.20 (6), p.657-660</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4055-53588bb74d9c6a2566c9b606f8716f63960194f12d61a60942a79ce3e02535be3</citedby><cites>FETCH-LOGICAL-c4055-53588bb74d9c6a2566c9b606f8716f63960194f12d61a60942a79ce3e02535be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-3083.2006.01495.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-3083.2006.01495.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16836491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baltás, E</creatorcontrib><creatorcontrib>Csoma, Z</creatorcontrib><creatorcontrib>Bodai, L</creatorcontrib><creatorcontrib>Ignácz, F</creatorcontrib><creatorcontrib>Dobozy, A</creatorcontrib><creatorcontrib>Kemény, L</creatorcontrib><title>Treatment of atopic dermatitis with the xenon chloride excimer laser</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Background Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow‐band ultraviolet B.
Objective The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis.
Patients and methods Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus.
Results After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side‐effects were observed.
Conclusion These results suggest that the xenon chloride excimer laser is an effective and well‐tolerated treatment for localized atopic dermatitis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>atopic dermatitis</subject><subject>Chlorides</subject><subject>Dermatitis, Atopic - pathology</subject><subject>Dermatitis, Atopic - therapy</subject><subject>excimer laser</subject><subject>Female</subject><subject>Humans</subject><subject>Laser Therapy - adverse effects</subject><subject>Laser Therapy - methods</subject><subject>Male</subject><subject>phototherapy</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Xenon</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v1DAQhi0EotvCX0A-cUvwRzyJDxxQF5aiVZFQaREXy3EmWi_JZmt71fTfk7Cr9spcZqR5nxnpIYRylvOpPmxzXkCVSVbJXDAGOeOFVvn4giyeFi_JgmkBmdZKn5HzGLeMMc5V9ZqccagkFJovyPImoE097hIdWmrTsPeONhh6m3zykT74tKFpg3TE3bCjbtMNwTdIcXS-x0A7GzG8Ia9a20V8e-oX5OeXzzeXX7P199XV5ad15gqmVKakqqq6LotGO7BCAThdA4O2Kjm0IDUwrouWiwa4BaYLYUvtUCITE1qjvCDvj3f3Ybg_YEym99Fh19kdDodooIJClFxMweoYdGGIMWBr9sH3Njwazsxs0GzNLMrMosxs0PwzaMYJfXf6cah7bJ7Bk7Ip8PEYePAdPv73YfNteTtPE58deR8Tjk-8DX8MlLJU5u56ZZa_1Ur8kGvzS_4Fv_2NNw</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Baltás, E</creator><creator>Csoma, Z</creator><creator>Bodai, L</creator><creator>Ignácz, F</creator><creator>Dobozy, A</creator><creator>Kemény, L</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200607</creationdate><title>Treatment of atopic dermatitis with the xenon chloride excimer laser</title><author>Baltás, E ; Csoma, Z ; Bodai, L ; Ignácz, F ; Dobozy, A ; Kemény, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4055-53588bb74d9c6a2566c9b606f8716f63960194f12d61a60942a79ce3e02535be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>atopic dermatitis</topic><topic>Chlorides</topic><topic>Dermatitis, Atopic - pathology</topic><topic>Dermatitis, Atopic - therapy</topic><topic>excimer laser</topic><topic>Female</topic><topic>Humans</topic><topic>Laser Therapy - adverse effects</topic><topic>Laser Therapy - methods</topic><topic>Male</topic><topic>phototherapy</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Xenon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baltás, E</creatorcontrib><creatorcontrib>Csoma, Z</creatorcontrib><creatorcontrib>Bodai, L</creatorcontrib><creatorcontrib>Ignácz, F</creatorcontrib><creatorcontrib>Dobozy, A</creatorcontrib><creatorcontrib>Kemény, L</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baltás, E</au><au>Csoma, Z</au><au>Bodai, L</au><au>Ignácz, F</au><au>Dobozy, A</au><au>Kemény, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of atopic dermatitis with the xenon chloride excimer laser</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2006-07</date><risdate>2006</risdate><volume>20</volume><issue>6</issue><spage>657</spage><epage>660</epage><pages>657-660</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Background Narrow‐band ultraviolet B phototherapy is an effictive and safe treatment for atopic dermatitis. We have previously found that the 308 nm xenon chloride excimer laser was more effective than the narrow‐band ultraviolet B light for the treatment of psoriasis, suggesting that ultraviolet B laser might offer advantages over narrow‐band ultraviolet B.
Objective The purpose of this study was to evaluate the therapeutic efficacy of the 308 nm excimer laser in atopic dermatitis.
Patients and methods Fifteen patients with atopic dermatitis (less than 20% body area involvement) were treated with a xenon chloride excimer laser (XTRAC laser, Photomedex Inc.) twice weekly. The severity of the atopic dermatitis was assessed via (i) a clinical score characterizing the intensity of erythema, infiltration, lichenification and excoriation; (ii) the quality of life, determined by means of a questionnaire; and (iii) a visual linear analogue scale, with which the patients scored the severity of their pruritus.
Results After 1 month of laser therapy, the clinical scores were significantly lower than the initial values. Similar decreases were observed for the quality of life and pruritus scores. No serious or unpleasant side‐effects were observed.
Conclusion These results suggest that the xenon chloride excimer laser is an effective and well‐tolerated treatment for localized atopic dermatitis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16836491</pmid><doi>10.1111/j.1468-3083.2006.01495.x</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2006-07, Vol.20 (6), p.657-660 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68642712 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adolescent Adult atopic dermatitis Chlorides Dermatitis, Atopic - pathology Dermatitis, Atopic - therapy excimer laser Female Humans Laser Therapy - adverse effects Laser Therapy - methods Male phototherapy Quality of Life Severity of Illness Index Surveys and Questionnaires Treatment Outcome Xenon |
| title | Treatment of atopic dermatitis with the xenon chloride excimer laser |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A02%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20atopic%20dermatitis%20with%20the%20xenon%20chloride%20excimer%20laser&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Balt%C3%A1s,%20E&rft.date=2006-07&rft.volume=20&rft.issue=6&rft.spage=657&rft.epage=660&rft.pages=657-660&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/j.1468-3083.2006.01495.x&rft_dat=%3Cproquest_cross%3E68642712%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68642712&rft_id=info:pmid/16836491&rfr_iscdi=true |